ConductScience.org, home

Library / Genes

AR: androgen receptor

1 protein, 160 patents, 42 drugs, 1,392 trials, 12,883 NIH grants and 44,218 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolARHGNC
Nameandrogen receptorHGNC
NCBI Gene ID367NCBI Gene
HGNC IDHGNC:644HGNC
EnsemblENSG00000169083NCBI Gene
AliasesAIS, AR8, DHTR, HPCX3, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFMNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P10275Androgen receptor92095Ensembl, GeneID, HGNCUniProt

Patents 160

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026500894 A2026-01-091P10275Espacenet
US 12496301 B22025-12-161P10275Espacenet
EP 4650780 A22025-11-199504P10275Espacenet
EP 4641201 A22025-10-299752P10275Espacenet
JP 2025147176 A2025-10-0614741P10275Espacenet
US 12427144 B22025-09-301P10275Espacenet
JP 2025517969 A2025-06-129752P10275Espacenet
JP 2025517970 A2025-06-129504P10275Espacenet
WO 2025122895 A12025-06-121P10275Espacenet
JP 2025062604 A2025-04-144701P10275Espacenet

Drugs 42

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ABIRATERONECHEMBL254328Androgen Receptor antagonistANTAGONISTChEMBL
APALUTAMIDECHEMBL3183409Androgen Receptor antagonistANTAGONISTChEMBL
APC-100CHEMBL37676Androgen Receptor antagonistANTAGONISTChEMBL
AZD3514CHEMBL2346976Androgen Receptor modulatorMODULATORChEMBL
BICALUTAMIDECHEMBL409Androgen Receptor antagonistANTAGONISTChEMBL
CLASCOTERONECHEMBL3590187Androgen Receptor antagonistANTAGONISTChEMBL
CR 1447CHEMBL3545092Androgen Receptor agonistAGONISTChEMBL
CYPROTERONE ACETATECHEMBL139835Androgen Receptor antagonistANTAGONISTChEMBL
DANAZOLCHEMBL1479Androgen Receptor agonistAGONISTChEMBL
DAROLUTAMIDECHEMBL4297185Androgen Receptor antagonistANTAGONISTChEMBL

Trials 1392

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07592910ENZALUTAMIDEPHASE2ClinicalTrials.gov
NCT07570979ENZALUTAMIDEPHASE1ClinicalTrials.gov
NCT07570979ABIRATERONEPHASE1ClinicalTrials.gov
NCT07553988ABIRATERONEPHASE2ClinicalTrials.gov
NCT07550517TESTOSTERONEPHASE2ClinicalTrials.gov
NCT07516704TESTOSTERONEEARLY_PHASE1ClinicalTrials.gov
NCT07516704DAROLUTAMIDEEARLY_PHASE1ClinicalTrials.gov
NCT07513480CYPROTERONE ACETATEClinicalTrials.gov
NCT07512076ENZALUTAMIDEPHASE2ClinicalTrials.gov
NCT07503379TESTOSTERONEPHASE2ClinicalTrials.gov

NIH grants 12883

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant4202,025NIH's project files
P50CA097186The Pacific Northwest Prostate Cancer SPORE3052,025NIH's project files
P30CA016672Cancer Center Support Grant2302,025NIH's project files
P30CA006973Regional Oncology Research Center2142,025NIH's project files
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer1642,025NIH's project files
P50CA092629SPORE in Prostate Cancer1402,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant1252,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant862,025NIH's project files
P50CA186786Michigan Prostate SPORE 2025-2030812,025NIH's project files
P30CA093373Cancer Center Support Grant P30782,025NIH's project files

Papers 44218

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826195PubTator, text miningPubMed
42825379PubTator, text miningPubMed
42823706PubTator, text miningPubMed
42823563PubTator, text miningPubMed
42823553PubTator, text miningPubMed
42823066PubTator, text miningPubMed
42819163PubTator, text miningPubMed
42818066PubTator, text miningPubMed
42815211PubTator, text miningPubMed
42814119PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license